Latest Cancer News

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults (05-24-2018)
Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra... Continue Reading

FDA Approves Aliqopa for Relapsed Follicular Lymphoma (05-23-2018)
The U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa® (copanlisib), a novel precision cancer medicine that inhibits phosphatidylinositol 3-kinase (PI3K), for the treatment... Continue Reading

FDA Approves Kymriah for Treatment of Relapsed or Refractory Large B-Cell Lymphoma (05-21-2018)
On May 1, 2018, the United States Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel), a CD19-directed genetically modified autologous T-cell immunotherapy, for treatment of adult patients... Continue Reading

More Cancer News

Locations

Alaska Oncology & Hematology, LLC
2925 DeBarr Road, Building D, Suite 300
Anchorage, Alaska 99508

Phone No. (907) 279-3155
Fax No. (907) 279-3154